Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anemia in CKD Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07487727
What this trial is testing

AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD)

Who this might be right for
Anemia Due to Chronic Kidney Disease
Kind Pharmaceuticals LLC 240
Large-scale testing (Phase 3)Study completedNCT00440557
What this trial is testing

An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease

Who this might be right for
Anemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 375
Not applicableStudy completedNCT07517744
What this trial is testing

Comparison Between Darbapoeitin Alpha and Roxadustat in CKD-related Anemia

Who this might be right for
CKD AnemiaCKD Anemia in Stable Dialysis Patients
Ain Shams University 35
Large-scale testing (Phase 3)Study completedNCT02780141
What this trial is testing

Intermittent Oral Dosing of ASP1517 in Erythropoieses Stimulating Agent (ESA)-Naive Hemodialysis Chronic Kidney Disease Patients With Anemia

Who this might be right for
ESA-naive Hemodialysis Chronic Kidney Disease Patients With Anemia
Astellas Pharma Inc 75
Post-approval studies (Phase 4)Study completedNCT00773513
What this trial is testing

Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)

Who this might be right for
Chronic Renal Anemia
Hoffmann-La Roche 2,825
Large-scale testing (Phase 3)Study completedNCT00548691
What this trial is testing

Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients

Who this might be right for
Anemia
American Regent, Inc. 513
Large-scale testing (Phase 3)UnknownNCT03521713
What this trial is testing

To Evaluate the Efficacy, Safety, and Immunogenicity of Subcutaneous Eporon Versus Epoetin Alfa (Eprex)

Who this might be right for
Anemia of Chronic Kidney Disease
Dong-A ST Co., Ltd. 214
Post-approval studies (Phase 4)Study completedNCT06556134
What this trial is testing

Oral Liposomal Iron Versus Injectable Iron Sucrose for Anemia Treatment in Non-Dialysis Chronic Kidney Disease Patients

Who this might be right for
Anemia of Chronic Kidney Disease
Centre Hospitalier Hassan II - Fès 27
Testing effectiveness (Phase 2)Ended earlyNCT00372489
What this trial is testing

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Affymax 81
Large-scale testing (Phase 3)Study completedNCT00546481
What this trial is testing

Intravenous Mircera for the Correction of Anemia in Dialysis Patients.

Who this might be right for
Anemia
Hoffmann-La Roche 80
Not applicableStudy completedNCT01121237
What this trial is testing

MONITOR-CKD5 - Multi-level Evaluation of Anaemia Treatment, Outcomes, and Determinants in Chronic Kidney Disease Stage 5

Who this might be right for
Chronic Kidney DiseaseEnd-stage Renal DiseaseAnaemia
Sandoz 2,086
Not applicableStudy completedNCT03643601
What this trial is testing

A Non-interventional, Epidemiological, Registry-based Evaluation of Anaemia in Swedish Patients With Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease Associated Anemia
Astellas Pharma a/s 14,415
Testing effectiveness (Phase 2)Looking for participantsNCT07725497
What this trial is testing

Luspatercept in People With Anemia

Who this might be right for
AnemiaChronic Kidney Disease
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)UnknownNCT02366325
What this trial is testing

Safety & Efficacy of EPO-018B for the Treatment of Anemia in Participants With ERSD Receiving Maintenance Hemodialysis

Who this might be right for
Chronic Renal FailureAnemia
Jiangsu Hansoh Pharmaceutical Co., Ltd. 60
Not applicableStudy completedNCT03220685
What this trial is testing

Relationship Between Gut Microbiota And Anemia In Patients With Chronic Renal Failure

Who this might be right for
Gut Micrbota and Its Relation to Anemia of CKD Patients
Assiut University 50
Large-scale testing (Phase 3)Study completedNCT04012957
What this trial is testing

Desidustat in the Treatment of Anemia in CKD

Who this might be right for
Chronic Kidney Disease Stage 3AnemiaChronic Kidney Disease Stage 4+1 more
Zydus Lifesciences Limited 588
Large-scale testing (Phase 3)Study completedNCT00090753
What this trial is testing

Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia

Who this might be right for
Anemia
Hoffmann-La Roche 1,228
Large-scale testing (Phase 3)Study completedNCT00121602
What this trial is testing

Efficacy Study: Darbepoetin Alfa for the Treatment of Anemia in Patients With Chronic Kidney Disease

Who this might be right for
AnemiaKidney Disease
Amgen 446
Large-scale testing (Phase 3)Study completedNCT00597584
What this trial is testing

Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on Hemodialysis

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Affymax 823
Large-scale testing (Phase 3)Study completedNCT01887600
What this trial is testing

Roxadustat in the Treatment of Anemia in Chronic Kidney Disease Patients Not Requiring Dialysis

Who this might be right for
Anemia in Chronic Kidney Disease in Non-dialysis Patients
Astellas Pharma Europe B.V. 594
Next Page